Growth through acquisition Bausch + Lomb Surgical has recently expanded capabilities by acquiring Elios Vision to enhance glaucoma treatment offerings, signaling potential cross-sell opportunities with comprehensive ophthalmic disease management solutions and instruments.

glaucoma focus Recent launches of Pure-Line gases and ongoing ophthalmology-centric innovations indicate a strong emphasis on specialized surgical support tools; identify partner clinics and hospitals that perform advanced glaucoma and retina procedures for equipment upgrades or bundled solutions.

innovation legacy With a history of surgical innovation and notable milestones like Stellaris lineage, there is opportunity to position high-value integrated systems, training services, and adaptive accessories to expand procedural capabilities in OR environments.

mid market potential As a midsize player with substantial revenue and global reach, there is room to target regional distributors and hospital networks that seek scalable ophthalmic equipment portfolios and cross-border service agreements.

digital engagement Active tech stack and digital footprint suggest a receptive audience for remote demonstrations, virtual training, and content marketing partnerships; leverage CRM/marketing tech to nurture leads and accelerate procurement cycles.